Format

Send to

Choose Destination
Surg Oncol Clin N Am. 2013 Jul;22(3):545-61. doi: 10.1016/j.soc.2013.02.009. Epub 2013 Mar 13.

Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes.

Author information

1
Radiation Oncology Department, Duke University Medical Center, Durham, NC 27710, USA. Mark.dewhirst@duke.edu

Abstract

Because of the limitations of surgical resection, thermal ablation is commonly used for the treatment of hepatocellular carcinoma and liver metastases. Current methods of ablation can result in marginal recurrences of larger lesions and in tumors located near large vessels. This review presents a novel approach for extending treatment out to the margins where temperatures do not provide complete treatment with ablation alone, by combining thermal ablation with drug-loaded thermosensitive liposomes. A history of the development of thermosensitive liposomes is presented. Clinical trials have shown that the combination of radiofrequency ablation and doxorubicin-loaded thermosensitive liposomes is a promising treatment.

PMID:
23622079
PMCID:
PMC3738918
DOI:
10.1016/j.soc.2013.02.009
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center